Pharmacogenetics in the Treatment of Pre-Eclampsia: Current Findings, Challenges and Perspectives
Pre-eclampsia (PE) is defined as pregnancy-induced hypertension and proteinuria, and is a major cause of maternal and perinatal morbidity and mortality. A large subgroup of pregnant women with PE is nonresponsive to antihypertensive drugs, including methyldopa, nifedipine and hydralazine. Pharmacoge...
Sparad:
| Huvudupphovsmän: | , , , |
|---|---|
| Materialtyp: | Revisão |
| Språk: | engelska |
| Publicerad: |
2017
|
| Länkar: | https://doi.org/10.2217/pgs-2016-0198 https://www.futuremedicine.com/doi/pdf/10.2217/pgs-2016-0198 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|